Amgen Stock Hits 52-Week High as Wells Fargo Raises Price Target

Amgen's stock price has reached a fresh 52-week high in early September 2026, trading at around $444.12 USD on Nasdaq.

This is according to market data from MarketBeat and MarketScreener, which show that the shares have recovered strongly from a 52-week low of $269.77 USD over the past year, with a gain of more than 60% in that period.

The price target for Amgen has been raised by Wells Fargo to $435 USD from $400 USD, while maintaining an Equal Weight rating.